Coegin Pharma is a Nordic Biotech company dedicated to developing innovative drugs for cancer and kidney diseases, where the need for new treatments is vital.
Coegin Pharma is developing a new generation of medicines based on decades of successful research of the unique target enzyme cPLA₂α. The enzyme has shown to play a central role in a variety of inflammatory driven cancers and chronic kidney diseases.
Coegin Pharma is developing a new generation of medicines based on decades of successful research of the unique target enzyme cPLA₂α. The enzyme has shown to play a central role in a variety of inflammatory driven cancers and chronic kidney diseases.
Location: Sweden, Lund
Employees: 1-10
Founded date: 2005